Tag: Cemiplimab

Emerging intralesional therapies for BCC

Presented By
Dr Antonio Cozzio, Kantonsspital St Gallen, Switzerland
Conference
DDD 2025
Type
Peer-reviewed article

5 June 2025 11:30

Anti-PD-1/anti-LAG-3 combination highly effective in HER2-negative breast cancer

Presented By
Prof. Claudine Isaacs, Georgetown University Medical Center, DC, USA
Trial
Phase 2, I-SPY 2
Conference
SABCS 2022
Type
Peer-reviewed article

1 February 2023 17:42

First-line immune checkpoint inhibition in metastatic NSCLC

Conference
ESMO 2020
Type
Peer-reviewed article

25 November 2020 15:00
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com